|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| (11) | Number of the document | 3916392 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21170716.1 |
| Date of filing the European patent application | 2017-05-30 | |
| (97) | Date of publication of the European application | 2021-12-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-01 |
| (46) | Date of publication of the claims translation | 2024-08-26 |
| (30) | Number | Date | Country code |
| 16171885 | 2016-05-30 | EP |
| (72) |
ENDELL, Jan , DE
WINDERLICH, Mark , DE
BOXHAMMER, Rainer , DE
|
| (73) |
Incyte Corporation ,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pacientų gydymo anti-CD19 terapinės naudos prognozavimo būdai |
| METHODS FOR PREDICTING THERAPEUTIC BENEFIT OF ANTI-CD19 THERAPY IN PATIENTS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 9 | 208.00 EUR |
| 2026-05-30 |